Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort

Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Custovic, Antoine Deschildre, Wanda Phipatanakul, Gary Wong, Paraskevi Xepapadaki, Rola Abou-Taam, Ioana Agache, Jose A. Castro-Rodriguez, Zhimin Chen, Pierrick Cros, Jean-Christophe Dubus, Zeinab Awad El-Sayed, Rasha El-Owaidy, Wojciech Feleszko, Vincenzo Fierro, Alessandro Fiocchi, Luis Garcia-Marcos, Anne Goh, Elham M. Hossny, Yunuen R. Huerta Villalobos, Tuomas Jartti, Pascal Le Roux, Julia Levina, Aida Inés López García, Ángel Mazón Ramos, Mário Morais-Almeida, Clare Murray, Karthik Nagaraju, Major K Nagaraju, Elsy Maureen Navarrete Rodriguez, Leyla Namazova-Baranova, Antonio Nieto Garcia, Cesar Fireth Pozo Beltrán, Thanaporn Ratchataswan, Daniela Rivero Yeverino, Eréndira Rodríguez Zagal, Cyril E Schweitzer, Marleena Tulkki, Katarzyna Wasilczuk, Dan Xu, PeARL collaborators on behalf of the PeARL Think Tank
doi: https://doi.org/10.1101/2020.10.27.20219436
Nikolaos G. Papadopoulos
1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
2nd, Athens, Greece
MD, PhD, FRCP, FAAAAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ngpallergy{at}gmail.com
Alexander G. Mathioudakis
1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
3North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
MD, MRCP(UK)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adnan Custovic
4Imperial College London, London, UK
MSc, DM, MD, PhD, FRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Deschildre
5Univ. Lille, INSERM Unit 1019, CNRS UMR 8204, Institut Pasteur de Lille, Center for infection and immunity of Lille, 59019 Lille cedex, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanda Phipatanakul
6Department of Allergy and Immunology, Boston Children’s Hospital, Boston, Massachusetts, USA
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Wong
7Department of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong
MD, FRCPC, FHKAM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paraskevi Xepapadaki
2nd, Athens, Greece
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rola Abou-Taam
8Pediatric Pulmonology and Allergy Department Hôpital Necker-Enfants Malades, Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioana Agache
9Allergy & Clinical Immunology, Transylvania University, Brasov, Romania
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose A. Castro-Rodriguez
10Department of Pediatric Pulmonology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhimin Chen
11Department of pulmonology, the children’s hospital, Zhejiang University school of medicine, national clinical research center for child health, Hangzhou, Zhejiang, China
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierrick Cros
12Department of Pediatrics, University Hospital Morvan, Brest, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Christophe Dubus
13Centre de Ressources et de Compétences pour la Mucoviscidose Pneumo-Allergologie, Ventilation, Maladies Respiratoires Rares de l’Enfant CHU Timone-Enfants, Marseille, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeinab Awad El-Sayed
14Pediatric Allergy and Immunology Unit, Children’s Hospital, Ain Shams University, Cairo, Egypt
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rasha El-Owaidy
14Pediatric Allergy and Immunology Unit, Children’s Hospital, Ain Shams University, Cairo, Egypt
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wojciech Feleszko
15Department of Pediatric Pneumonology and Allergy, The Medical University of Warsaw, Warsaw, Poland
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincenzo Fierro
16Allergy Department, Bambino Gesù Children’s Hospital IRCCS, Roma – Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Fiocchi
16Allergy Department, Bambino Gesù Children’s Hospital IRCCS, Roma – Italy
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis Garcia-Marcos
17Pediatric Respiratory and Allergy Units, “Virgen de la Arrixaca” Children’s University Clinical Hospital, University of Murcia, Murcia, Spain
18Institute for Biomedical Research of Murcia, IMIB-Arrixaca; & Network of Asthma and Adverse and Allergic Reactions (ARADyAL), Murcia, Spain
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Goh
19Department of Internal Medicine, Rush Medical College, Chicago
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elham M. Hossny
14Pediatric Allergy and Immunology Unit, Children’s Hospital, Ain Shams University, Cairo, Egypt
MD, PhD, FAAAAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunuen R. Huerta Villalobos
20Hospital General Regional 1 “Dr. Carlos Mac Gregor Sánchez Navarro” IMSS, Mexico
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuomas Jartti
21Department of Pediatrics and Adolescent Medicine, Oulu University Hospital and University of Oulu, Oulu, Finland
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Le Roux
22Department of pediatrics, Groupe hospitalier Le Havre, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Levina
23Pediatric and Child Health Research Institute of the Central Clinical Hospital of the Russian Academy of Sciences, Russia
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aida Inés López García
24Allergy and Clinical Immunology Service of the University Hospital of Puebla, Mexico
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ángel Mazón Ramos
25Pediatric Pulmonology & Allergy Unit Children’s Hospital la Fe, Valencia, Spain
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mário Morais-Almeida
26Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal
MD, MSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Murray
1Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK
MBChB, MD, MRCP, MRCPHCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Nagaraju
27VN Allergy & Asthma Research Centre, Chennai, Tamilnadu, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Major K Nagaraju
28Professor & Head, Department of Allergy & Clinical Immunology, Saveetha Medical College, Chennai, India
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elsy Maureen Navarrete Rodriguez
29Pediatric Allergy and Clinical Immunology Service, Hospital Infantil, til de México Federico Gómez, Mexico
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leyla Namazova-Baranova
23Pediatric and Child Health Research Institute of the Central Clinical Hospital of the Russian Academy of Sciences, Russia
30Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Russia
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Nieto Garcia
25Pediatric Pulmonology & Allergy Unit Children’s Hospital la Fe, Valencia, Spain
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cesar Fireth Pozo Beltrán
31Teaching and Research Department and Paediatric Allergy department, Hospital with Specialties Juan María de Salvatierra, La Paz, Baja California Sur México
32Allergy & immunology Department Hospital Infantil de Medico Federico Gomez, Mexico City
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thanaporn Ratchataswan
6Department of Allergy and Immunology, Boston Children’s Hospital, Boston, Massachusetts, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Rivero Yeverino
33Allergy and Clinical Immunology Department, Hospital Universitario de Puebla, Puebla, México
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eréndira Rodríguez Zagal
20Hospital General Regional 1 “Dr. Carlos Mac Gregor Sánchez Navarro” IMSS, Mexico
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cyril E Schweitzer
34CHRU de Nancy, Hôpital d’Enfants, Rue du Morvan, 54511 Vandoeuvre, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marleena Tulkki
35Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katarzyna Wasilczuk
15Department of Pediatric Pneumonology and Allergy, The Medical University of Warsaw, Warsaw, Poland
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Xu
11Department of pulmonology, the children’s hospital, Zhejiang University school of medicine, national clinical research center for child health, Hangzhou, Zhejiang, China
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Importance Importance: The interplay between COVID-19 pandemic and asthma in children is still unclear.

Objective We evaluated the impact of COVID-19 pandemic on childhood asthma outcomes.

Design The PeARL multinational cohort included children with asthma and non-asthmatic controls recruited during the COVID-19 pandemic and compared current disease activity with data available from the previous year.

Setting Pediatric outpatient clinics.

Participants The study included 1,054 children with asthma and 505 non-asthmatic controls, aged between 4-18 years, from 25 pediatric departments, from 15 countries globally.

Exposures COVID-19 pandemic first wave, starting from the date of the first fatality in the respective country.

Main outcomes and measures We assessed the pandemic’s impact on the frequency of respiratory infections, emergency presentations and hospital admissions in asthmatic versus non-asthmatic participants, controlling for confounding factors including the pandemic’s duration and the frequency of such acute events during 2019. Using paired analyses, we evaluated the impact of the pandemic on the annualized frequency of asthma attacks and the previously mentioned acute events, asthma control, and pulmonary function in children with asthma, compared to their baseline disease activity, during the preceding year.

Results During the pandemic, children with asthma experienced fewer upper respiratory tract infections, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks and hospitalizations due to asthma, in comparison to the preceding year. Sixty-six percent of asthmatic children had improved asthma control while in 33% the improvement exceeded the minimally clinically important difference. Pre-bronchodilatation FEV1 and peak expiratory flow rate were also improved during the pandemic.

When compared to non-asthmatic controls, children with asthma were not found to be at increased risk of LRTIs, episodes of pyrexia, emergency visits or hospitalizations during the pandemic. However, an increased risk of URTIs emerged.

Conclusions and relevance Childhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent.

Question What was the impact of COVID-19 pandemic on childhood asthma outcomes?

Findings During the first wave of the pandemic, children with asthma have experienced improved outcomes, as evidenced by fewer asthma attachks, hospitalizations, improved scores in validated asthma control measures and improved pulmonary function.

Meaning This is the first study to show a positive impact of COVID-19 pandemic on childhood asthma activity. This is probably the result of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the hypothesis that childhood asthma may be a risk factor for COVID-19.

Competing Interest Statement

TJ reports grants from The Paulo Foundation, Helsinki, Finland. MT reports grants from The Sigrid Juselius Foundation, Helsinki, Finland, during the conduct of the study. None of the other authors had any conflicts of interest directly related to this work. AND, AF, KN, EH, LN-B, WP, ZC, WF, GW, LG-M, ZAW-S, YRHV, CFPB, DRY, CS, PLR, PS, RA-T, J-CD, JL, TR, DY, AMR, KW, RE-O, JAC-R, AG, CM, AILG, MM-A, EMNR, MKN, VF do not declare any conflicts of interest outside the submitted work either. NGP reports personal fees from ALK, Novartis, Nutricia, HAL, Menarini/FAES Farma, Sanofi, Mylan/MEDA, Biomay, AstraZeneca, GSK, MSD, ASIT BIOTECH and Boehringer Ingelheim; grants from Gerolymatos International SA and Capricare outside the submitted work. AGM reports grants from Boehringer Ingelheim outside the submitted work. AC reports personal fees from Novartis, Thermo Fisher Scientific, Philips, Sanofi, Stallergenes Greer, AstraZeneca, outside the submitted work. AD reports personal fees and other from Novartis, ALK, MYLAN, GSK, CHIESI, Astra Zeneca, DBV technologies, grants and personal fees from Stallergenes Greer, personal fees from AImmune, Zambon, Boehringer Ingelheim, Nestle HealthScience, other from Nutricia, outside the submitted work. IA reports and Associate Editor Allergy journal. PX reports personal fees from Nutricia, Nestle, Friesland, Uriach, Novartis Pharma AG, and GlaxoSmithkline outside the submitted work. CM reports personal fees from Novartis, GSK, ThermoFisher, Boehringer Ingelheim, outside the submitted work

Funding Statement

This study was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis and Sanofi for continued work on PeARL.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics review board, General Pediatric Hospital "Panagiotis & Aglaia Kyriakou", Athens, Greece. Athens 24-06-2020 Reference number: 11814.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* PeARL collaborators: Anna Alekseeva, Bethan Almeida, Maud Andre, Polina Arimova, Aurore Blonde, Amparito Cunningham, Sofia Da Mota, Kamilla Efendieva, Vera Kalugina, Sébastien Kiefer, Anais Klein, Chrystopherson Gengyny Caballero López, Juan Jesús Ríos López, Caroline Moratellti, Miguel Fuentes Pérez, Meryl Simermann, José Sergio Papaqui Tapia, Aurelie Tatopoulos, Elena Vishneva, Konstantin Volkov.

  • ** PeARL Think Tank: Ioana Agache, Zeinab Awad El-Sayed, Leonard Bacharier, Matteo Bonini, Jose Castro-Rodriguez, Zhimin Chen, Timothy Craig, Adnan Custovic, Antoine Deschildre, Zuzana Diamant, Francine M. Ducharme, Wojciech Feleszko, Alessandro Fiocchi, Luis Garcia-Marcos, James E Gern, Anne Goh, Jonathan Grigg, Eckard H. Hamelmann, Gunilla Hedlin, Elham M. Hossny, Tuomas Jartti, Omer Kalayci, Alan Kaplan, Jon Konradsen, Piotr Kuna, Susanne Lau, Peter Le Souef, Robert F. Lemanske, Mika J Makela, Alexander G. Mathioudakis, Paolo M. Matricardi, René Maximiliano Gómez, Michael Miligkos, Mário Morais-Almeida, Clare Murray, Leyla Namazova-Baranova, Antonio Nieto Garcia, Nikolaos G. Papadopoulos, Wanda Phipatanakul, Paulo MC Pitrez, David Price, Petr Pohunek, Graham C. Roberts, Aziz Sheikh, Ioanna Tsiligianni, Steve Turner, Arunas Valiulis, Tonya Winders, Gary Wong, Paraskevi Xepapadaki, Osman M. Yusuf, Heather Zar.

  • Declaration of Interests: This study was supported by the Respiratory Effectiveness Group (REG). REG has received support from AstraZeneca, Novartis and Sanofi for continued work on PeARL.

  • TJ reports grants from The Paulo Foundation, Helsinki, Finland. MT reports grants from The Sigrid Juselius Foundation, Helsinki, Finland, during the conduct of the study. None of the other authors had any conflicts of interest directly related to this work.

  • AND, AF, KN, EH, LN-B, WP, ZC, WF, GW, LG-M, ZAW-S, YRHV, CFPB, DRY, CS, PLR, PS, RA-T, J-CD, JL, TR, DY, AMR, KW, RE-O, JAC-R, AG, CM, AILG, MM-A, EMNR, MKN, VF do not declare any conflicts of interest outside the submitted work either. NGP reports personal fees from ALK, Novartis, Nutricia, HAL, Menarini/FAES Farma, Sanofi, Mylan/MEDA, Biomay, AstraZeneca, GSK, MSD, ASIT BIOTECH and Boehringer Ingelheim; grants from Gerolymatos International SA and Capricare outside the submitted work. AGM reports grants from Boehringer Ingelheim outside the submitted work.. AC reports personal fees from Novartis, Thermo Fisher Scientific, Philips, Sanofi, Stallergenes Greer, AstraZeneca, outside the submitted work. AD reports personal fees and other from Novartis, ALK, MYLAN, GSK, CHIESI, Astra Zeneca, DBV technologies, grants and personal fees from Stallergenes Greer, personal fees from AImmune, Zambon, Boehringer Ingelheim, Nestlé HealthScience, other from Nutricia, outside the submitted work. IA reports and Associate Editor Allergy journal. PX reports personal fees from Nutricia, Nestle, Friesland, Uriach, Novartis Pharma AG, and GlaxoSmithkline outside the submitted work. CM reports personal fees from Novartis, GSK, ThermoFisher, Boehringer Ingelheim, outside the submitted work.

Data Availability

Deidentified patient level data will be available upon request between 3 months and 5 years after the publication of this manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Custovic, Antoine Deschildre, Wanda Phipatanakul, Gary Wong, Paraskevi Xepapadaki, Rola Abou-Taam, Ioana Agache, Jose A. Castro-Rodriguez, Zhimin Chen, Pierrick Cros, Jean-Christophe Dubus, Zeinab Awad El-Sayed, Rasha El-Owaidy, Wojciech Feleszko, Vincenzo Fierro, Alessandro Fiocchi, Luis Garcia-Marcos, Anne Goh, Elham M. Hossny, Yunuen R. Huerta Villalobos, Tuomas Jartti, Pascal Le Roux, Julia Levina, Aida Inés López García, Ángel Mazón Ramos, Mário Morais-Almeida, Clare Murray, Karthik Nagaraju, Major K Nagaraju, Elsy Maureen Navarrete Rodriguez, Leyla Namazova-Baranova, Antonio Nieto Garcia, Cesar Fireth Pozo Beltrán, Thanaporn Ratchataswan, Daniela Rivero Yeverino, Eréndira Rodríguez Zagal, Cyril E Schweitzer, Marleena Tulkki, Katarzyna Wasilczuk, Dan Xu, PeARL collaborators
medRxiv 2020.10.27.20219436; doi: https://doi.org/10.1101/2020.10.27.20219436
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Custovic, Antoine Deschildre, Wanda Phipatanakul, Gary Wong, Paraskevi Xepapadaki, Rola Abou-Taam, Ioana Agache, Jose A. Castro-Rodriguez, Zhimin Chen, Pierrick Cros, Jean-Christophe Dubus, Zeinab Awad El-Sayed, Rasha El-Owaidy, Wojciech Feleszko, Vincenzo Fierro, Alessandro Fiocchi, Luis Garcia-Marcos, Anne Goh, Elham M. Hossny, Yunuen R. Huerta Villalobos, Tuomas Jartti, Pascal Le Roux, Julia Levina, Aida Inés López García, Ángel Mazón Ramos, Mário Morais-Almeida, Clare Murray, Karthik Nagaraju, Major K Nagaraju, Elsy Maureen Navarrete Rodriguez, Leyla Namazova-Baranova, Antonio Nieto Garcia, Cesar Fireth Pozo Beltrán, Thanaporn Ratchataswan, Daniela Rivero Yeverino, Eréndira Rodríguez Zagal, Cyril E Schweitzer, Marleena Tulkki, Katarzyna Wasilczuk, Dan Xu, PeARL collaborators
medRxiv 2020.10.27.20219436; doi: https://doi.org/10.1101/2020.10.27.20219436

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)